← Back to Search

Online Relapse Prevention Methods for Eating Disorders (ORP Trial)

N/A
Waitlist Available
Led By Cheri A Levinson, PhD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
over the age of 18
currently meet criteria for anorexia nervosa, other specified feeding and eating disorder-atypical anorexia nervosa, or bulimia nervosa
Must not have
under the age of 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month follow up and 6 month follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing two different methods for preventing relapse after treatment for eating disorders: imaginal exposure therapy and writing and thinking intervention. The goal is to see if either method is more effective than the other, and if so, to understand why.

Who is the study for?
This trial is for adults over 18 who've recently left intensive treatment for eating disorders like anorexia or bulimia. It's not suitable for those with severe mental health issues, medical instability, or anyone discharged from care over a month ago.
What is being tested?
The study compares two relapse-prevention methods post-eating disorder treatment: imaginal exposure therapy and a writing/thinking task. It aims to see which better prevents relapse and improves symptoms and fears related to eating disorders.
What are the potential side effects?
While specific side effects are not detailed, interventions may trigger emotional discomfort due to confronting fears in the case of imaginal exposure, or stress from introspection during writing tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I have been diagnosed with anorexia, atypical anorexia, or bulimia.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am younger than 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month follow up and 6 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month follow up and 6 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Eating Disorder Symptoms using the EDE-Q
Rate of Eating Disorder Relapse
Re-admission Percentage
Secondary study objectives
Change in Eating Disorder Symptoms
Change in Positive and Negative Affect
Change in State Anxiety
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Imaginal Exposure ConditionExperimental Treatment1 Intervention
Participants will complete one phone session including education about the treatment followed by four online sessions of imaginal exposure across a one month time period. Each session is separated by 1 week.
Group II: Writing and Thinking ConditionActive Control1 Intervention
Participants will complete one phone session including education about the treatment followed by four online sessions of a writing and thinking intervention across a one month time period. Each session is separated by 1 week.

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor
345 Previous Clinical Trials
77,285 Total Patients Enrolled
2 Trials studying Bulimia Nervosa
251 Patients Enrolled for Bulimia Nervosa
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,835 Total Patients Enrolled
27 Trials studying Bulimia Nervosa
41,292 Patients Enrolled for Bulimia Nervosa
King's College LondonOTHER
757 Previous Clinical Trials
26,129,003 Total Patients Enrolled
3 Trials studying Bulimia Nervosa
410 Patients Enrolled for Bulimia Nervosa

Media Library

Imaginal Exposure Condition Clinical Trial Eligibility Overview. Trial Name: NCT04862247 — N/A
Bulimia Nervosa Research Study Groups: Imaginal Exposure Condition, Writing and Thinking Condition
Bulimia Nervosa Clinical Trial 2023: Imaginal Exposure Condition Highlights & Side Effects. Trial Name: NCT04862247 — N/A
Imaginal Exposure Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT04862247 — N/A
~6 spots leftby Feb 2025